|
News Briefs Herpes Vaccine Trial Needs 7,500 WomenNovember 26, 2002 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! For a new vaccine trial, the National Institute of Allergy and Infectious Diseases is working with GlaxoSmithKline to find a rare population of women -- those who have never been infected with genital herpes or the cold sore virus, both of which are incredibly common. Researchers hope the new vaccine will win approval based on the trial's results. "More than 1 million new cases of genital herpes are diagnosed in the United States each year," NIAID Director Dr. Anthony Fauci said last week. The trial was set up just a day after researchers confirmed the vaccine can prevent up to 70 percent of genital herpes infections among women; it does not seem to work for men, however. For more information about the trial, visit www.niaid.nih.gov/dmid/stds/herpevac/. Back to other CDC news for November 26, 2002 Detroit Free Press 11.26.02 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|